{"id":10458,"date":"2017-07-25T16:01:53","date_gmt":"2017-07-25T14:01:53","guid":{"rendered":"https:\/\/news.embl.de\/?p=10458"},"modified":"2025-11-19T12:58:01","modified_gmt":"2025-11-19T11:58:01","slug":"1707-new-england-biolabs-partners-embl","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/","title":{"rendered":"New England Biolabs partners with EMBL"},"content":{"rendered":"\n<p>EMBL welcomes <a href=\"http:\/\/www.neb.com\">New England Biolabs (NEB)<\/a> as the newest member of the <a href=\"https:\/\/www.embl.de\/aboutus\/support-embl\/corporate-partnership-programme\/index.html\">EMBL Advanced Training Centre (ATC) Corporate Partnership Programme<\/a>. Together, EMBL and NEB will collaborate to develop workshops and training opportunities in new areas of research.<\/p>\n\n\n\n<div class=\"wp-block-image vf-u-width__40\"><figure class=\"vf-figure  | vf-figure--align vf-figure--align-inline-end  size-full\"><a href=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEB-ib.jpg\"><img loading=\"lazy\" decoding=\"async\" width=\"620\" height=\"425\" class=\"vf-figure__image\" src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEB-ib.jpg\" alt=\"New England biolabs logo\" class=\"wp-image-10460\" srcset=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEB-ib.jpg 620w, https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEB-ib-300x206.jpg 300w\" sizes=\"auto, (max-width: 620px) 100vw, 620px\" \/><\/a><\/figure><\/div>\n\n\n\n<p>\u201cThe success of the EMBL network over the years is quite impressive and convincing \u2013 not only for basic research, but also in the level of services that are being offered to the scientific community. This includes training courses that help introduce new technologies to the field,\u201d says Thomas Moellenkamp, General Manager of New England Biolabs GmbH. \u201cWe are excited to work with EMBL to help provide opportunities for young researchers to advance their training\u201d.<\/p>\n\n\n\n<p>NEB was founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry and is a recognised world leader in the discovery, development and commercialisation of recombinant and native enzymes for genomic research.<\/p>\n\n\n\n<p>\u201cNEB\u2019s support for molecular biologists is longstanding and considerable,\u201d says Vladimir Benes, Head of EMBL\u2019s <a href=\"https:\/\/www.embl.de\/services\/core_facilities\/genecore\/index.html\">Genomics Core Facility<\/a>. \u201cTheir innovative solutions for genomic research will strengthen our portfolio of advanced training.\u201d<\/p>\n\n\n\n<p>\u201cWe very much look forward to a successful and collaborative partnership with NEB,\u201d adds EMBL\u2019s Antonio Costantino,&nbsp;<span class=\"s1\">who coordinates the activities of the Corporate Partnership Programme<\/span>.<\/p>\n\n\n\n<p>NEB joins a group of world-leading corporate partners who participate in the Corporate Partnership Programme, EMBL\u2019s platform for fostering advanced training collaborations and community building initiatives to connect industry and academia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>NEB joins EMBL\u2019s corporate partnership programme<\/p>\n","protected":false},"author":44,"featured_media":10461,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17595,3],"tags":[172,43,25,13072],"embl_taxonomy":[19535,5802],"class_list":["post-10458","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-connections","category-lab-matters","tag-corporate-partnership-programme","tag-heidelberg","tag-partnerships","tag-support-embl","embl_taxonomy-corporate-partnership-programme","embl_taxonomy-support-embl"],"acf":{"article_intro":"<p>Collaboration aims to strengthen training opportunities in the latest technologies for young researchers<\/p>\n","related_links":[{"link_description":"","link_url":""},{"link_description":"","link_url":""},{"link_description":"","link_url":""}],"article_sources":false,"vf_locked":false,"featured":false,"color":"#007B53","show_featured_image":false,"field_target_display":"embl","source_article":false,"in_this_article":false,"press_contact":"None","vfwp-news_embl_taxonomy":[19535,5802],"field_article_language":{"value":"english","label":"English"},"article_translations":false,"languages":""},"embl_taxonomy_terms":[{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";i:2;s:36:\"0d3270ca-455c-428a-86f4-c61b1de8c3e0\";}","parents":[],"name":["Corporate Partnership Programme"],"slug":"corporate-partnership-programme","description":"What &gt; Support EMBL &gt; Corporate Partnership Programme"},{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"bc1eaadd-1f50-4140-8e9b-e58fc33a39fc\";i:2;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";}","parents":[],"name":["Support EMBL"],"slug":"support-embl","description":"What &gt; About EMBL &gt; Support EMBL"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>New England Biolabs becomes EMBL&#039;s latest corporate partners<\/title>\n<meta name=\"description\" content=\"New England Biolabs joins EMBL&#039;s corporate partnership programme to promote training and workshops in new technologies\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New England Biolabs becomes EMBL&#039;s latest corporate partners\" \/>\n<meta property=\"og:description\" content=\"New England Biolabs joins EMBL&#039;s corporate partnership programme to promote training and workshops in new technologies\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-25T14:01:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-19T11:58:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"425\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Laura Howes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laura Howes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/\"},\"author\":{\"name\":\"Laura Howes\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/7d5e14088f1a79e8e3564e6f712c9263\"},\"headline\":\"New England Biolabs partners with EMBL\",\"datePublished\":\"2017-07-25T14:01:53+00:00\",\"dateModified\":\"2025-11-19T11:58:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/\"},\"wordCount\":252,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg\",\"keywords\":[\"corporate partnership programme\",\"heidelberg\",\"partnerships\",\"support embl\"],\"articleSection\":[\"Connections\",\"Lab Matters\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/\",\"url\":\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/\",\"name\":\"New England Biolabs becomes EMBL's latest corporate partners\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg\",\"datePublished\":\"2017-07-25T14:01:53+00:00\",\"dateModified\":\"2025-11-19T11:58:01+00:00\",\"description\":\"New England Biolabs joins EMBL's corporate partnership programme to promote training and workshops in new technologies\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg\",\"width\":620,\"height\":425,\"caption\":\"Training at EMBL\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/7d5e14088f1a79e8e3564e6f712c9263\",\"name\":\"Laura Howes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/eba7878242e39af7c2cd6ede5a4037a9ceb88dcf7988718263c415e15c43dbdf?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/eba7878242e39af7c2cd6ede5a4037a9ceb88dcf7988718263c415e15c43dbdf?s=96&d=mm&r=g\",\"caption\":\"Laura Howes\"},\"url\":\"https:\/\/www.embl.org\/news\/author\/laura-howes\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New England Biolabs becomes EMBL's latest corporate partners","description":"New England Biolabs joins EMBL's corporate partnership programme to promote training and workshops in new technologies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/","og_locale":"en_US","og_type":"article","og_title":"New England Biolabs becomes EMBL's latest corporate partners","og_description":"New England Biolabs joins EMBL's corporate partnership programme to promote training and workshops in new technologies","og_url":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2017-07-25T14:01:53+00:00","article_modified_time":"2025-11-19T11:58:01+00:00","og_image":[{"width":620,"height":425,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg","type":"image\/jpeg"}],"author":"Laura Howes","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Laura Howes","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/"},"author":{"name":"Laura Howes","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/7d5e14088f1a79e8e3564e6f712c9263"},"headline":"New England Biolabs partners with EMBL","datePublished":"2017-07-25T14:01:53+00:00","dateModified":"2025-11-19T11:58:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/"},"wordCount":252,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg","keywords":["corporate partnership programme","heidelberg","partnerships","support embl"],"articleSection":["Connections","Lab Matters"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/","url":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/","name":"New England Biolabs becomes EMBL's latest corporate partners","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg","datePublished":"2017-07-25T14:01:53+00:00","dateModified":"2025-11-19T11:58:01+00:00","description":"New England Biolabs joins EMBL's corporate partnership programme to promote training and workshops in new technologies","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/lab-matters\/1707-new-england-biolabs-partners-embl\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg","width":620,"height":425,"caption":"Training at EMBL"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/7d5e14088f1a79e8e3564e6f712c9263","name":"Laura Howes","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/eba7878242e39af7c2cd6ede5a4037a9ceb88dcf7988718263c415e15c43dbdf?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/eba7878242e39af7c2cd6ede5a4037a9ceb88dcf7988718263c415e15c43dbdf?s=96&d=mm&r=g","caption":"Laura Howes"},"url":"https:\/\/www.embl.org\/news\/author\/laura-howes\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2017\/07\/107-NEBEMBL-ib.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/10458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=10458"}],"version-history":[{"count":6,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/10458\/revisions"}],"predecessor-version":[{"id":77313,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/10458\/revisions\/77313"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/10461"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=10458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=10458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=10458"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=10458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}